CCJ

The Week

Cameco (CCJ) closed the week at $85.18, down 3.28%, while the S&P 500 fell 0.27%, leaving CCJ about 3.01 percentage points behind the benchmark. The five-day move was a fade from strength: Monday (Sep 28) opened at $86.80, Wednesday touched a weekly high of $89.92, then Thursday slid to an intraday low near $83.80 before Friday’s close at $85.18. The weekly range was 7.05%. Average daily volume was about 3.07m shares, close to the 60-day norm with no clear spike or contraction.

Key Events

This week’s news centred on the US–Korea nuclear framework. On Sep 30, Cameco said it was aware of the announcement by the United States and the Republic of Korea on a framework for deploying nuclear power. A day later, Brookfield Asset Management backed the same framework, pledging up to $120bn in financing. Separately, media coverage connected a US uranium import ban to supply-chain reshuffling, with Cameco among the sector’s relative outperformers. Other articles compared Cameco with Centrus Energy and flagged Canadian uranium names with expected earnings growth as high as 66%. No material company filings hit this week.

Analyst Ratings

As of Oct 2, 21 brokers cover Cameco: 11 rate it buy, 8 overweight and 2 hold, with no underperform or sell ratings. The consensus rating is buy and the consensus target is about $126.99, roughly 49.09% above the latest close of $85.18. Individual targets range from $83.237 to $169.333, a wide spread, though most sit above spot. Cameco ranks first within its industry coverage group, coal and consumable fuels.

The Week Ahead

Next week brings a run of US macro releases: the S&P Global services PMI final and ISM non-manufacturing PMI on Oct 5, followed by international trade data on Oct 6. These will set the tone for risk appetite and resource-linked stocks. For Cameco, the larger date is Oct 30, when the company reports fiscal Q3 2026 results before the open; consensus estimates are EPS of $0.2665 and revenue of $527m.

In Short

This week paired a supportive broker setup with a softer tape: most analysts rate Cameco buy and the consensus target sits well above spot, yet the stock gave back early-week gains and finished behind the S&P 500. Valuation remains steep at about 145.55x P/E and 7.39x P/B, and the latest session showed large-lot money leaning toward outflows. The next test is whether the Oct 30 earnings report backs current expectations, and whether the US–Korea framework turns into concrete contract follow-through.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.